Amarin Corp Plc (AMRN)

[ziploc_1]

J.T. had left Amarin and K.M. was new....Ekman was, at this time, calling the shots, selling all of the Amarin shares in the fund ,Sofinnova, where he was managing director and refusing to join in EPADI appeal...Now, for the first time, KM is in the driver's seat.

In the wake of the critical loss of the Marine patent, followed by the gV skinny label infringement on Vascepa's CVD indication, cutting expenses to the bone was an obviously necessary strategy and KM is doing just that.

I don't blame KM for the past management mistakes of JT, Kennedy, or Ekman.